Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PLX | ACIU | CHRS | ||
| Company | Protalix Biotherapeutics | AC Immune S.A. | Coherus Oncology Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 3.15 | 2.53 | 1.7000 | ||
| High | 3.15 | 2.59 | 1.7400 | ||
| Low | 3.00 | 2.49 | 1.6201 | ||
| Latest | 3.06 | 2.52 | 1.6300 | ||
| Change | -0.09 | -0.01 | -0.0800 | ||
| % Change | -2.86% | -0.40% | -4.68% | ||
| Volume | 1,334,200 | 279,700 | 1,368,500 | ||
| 20-Day Average Volume | 1,726,300 | 299,400 | 3,933,210 | ||
| Previous Close | 3.15 | 2.53 | 1.7100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.66 | 3.11 | 2.0403 | ||
| 20-Day Raw Stochastic | 90.39% | 4.83% | 4.83% | ||
| 20-Day Relative Strength | 70.64 | 35.84 | 45.38 | ||
| Weighted Alpha | +92.38 | -19.71 | +30.70 | ||
| Today's Opinion | 100% Buy | 24% Sell | 64% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 80% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.99% since 02/12/26 | -13.99% since 02/12/26 | -18.91% since 02/12/26 | ||
| Low | 2.81 on 02/13/26 | 2.45 on 02/18/26 | 1.5800 on 02/13/26 | ||
| High | 3.17 on 02/19/26 | 3.03 on 02/13/26 | 1.7950 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | +49.27% since 01/20/26 | -24.10% since 01/20/26 | +5.16% since 01/20/26 | ||
| Low | 1.97 on 01/21/26 | 2.45 on 02/18/26 | 1.5500 on 01/21/26 | ||
| High | 3.17 on 02/19/26 | 3.90 on 01/23/26 | 2.6158 on 01/27/26 | ||
| 3-Month | |||||
| %Chg | +75.86% since 11/20/25 | -13.40% since 11/20/25 | +48.18% since 11/20/25 | ||
| Low | 1.65 on 12/03/25 | 2.45 on 02/18/26 | 1.0900 on 11/21/25 | ||
| High | 3.17 on 02/19/26 | 3.90 on 01/23/26 | 2.6158 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +94.90% since 08/20/25 | +17.76% since 08/20/25 | +52.34% since 08/20/25 | ||
| Low | 1.52 on 09/05/25 | 2.03 on 08/29/25 | 1.0600 on 08/21/25 | ||
| High | 3.17 on 02/19/26 | 4.00 on 10/29/25 | 2.6158 on 01/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 246,088 | 253,033 | 243,638 | ||
| Shares Outstanding, K | 80,421 | 100,410 | 149,471 | ||
| Annual Sales | 53,400,000 | 31,020,000 | 266,960,000 | ||
| Annual Net Income | 2,930,000 | -57,840,000 | 28,510,000 | ||
| Last Quarter Sales | 17,850,000 | 1,170,000 | 11,570,000 | ||
| Last Quarter Net Income | 2,360,000 | -19,810,000 | -35,530,000 | ||
| 60-Month Beta | -0.21 | 1.66 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 11/13/25 | -0.20 on 11/04/25 | -0.33 on 11/06/25 | ||
| Latest Earnings Date | 03/16/26 | 03/12/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 45.00 | 0.00 | 0.00 | ||